|
Match
|
Document |
Document Title |
|
|
US20090214419 |
SELF-ASSEMBLED BIODEGRADABLE POLYMERSOMES
The invention concerns a block copolymer of polyethylene oxide and polycaprolactone, the polyethylene oxide having a number average molecular weight from about 2.0 to about 3.8 kD, the block...
|
|
|
US20090205056 |
METHOD OF SCREENING FOR MODULATORS OF MAP3K11 IN LIVER CANCER CELLS
Detection of expression of the provided protein kinase in cancers is useful as a diagnostic, for determining the effectiveness of drugs, and determining patient prognosis. The encoded polypeptides...
|
|
|
US20090180923 |
SELF-MIXING CONTAINER WITH A RELEASABLE INTERNAL VESSEL AND ITS USAGE
This application relates to a self-mixing container with a releasable internal vessel and its usage, wherein said self-mixing container comprises a container body, a double-walled external cap and...
|
|
|
US20090093538 |
Method for treating cancer
The invention relates to a method of treating cancer in a subject, comprising administering to the subject an anti-cancer therapy and a compound that increases the oxidative stress of the cancer...
|
|
|
US20080199407 |
Drug Detoxification Protocol Using Microdosing
This invention relates to use of an opioid receptor agonist in microdose quantities to reduce or eliminate the withdrawal symptoms associated with discontinuing drug use. The dosage of the agonist...
|
|
|
US20080145386 |
TRPV1+ sensory neurons control of beta-cell stress and islet inflammation in diabetes
A process is disclosed for controlling inflammatory tissue access through release of neuropeptides, such as substance P (sP), to insulin-responsive sensory neurons, whereby simultaneous control of...
|
|
|
US20080125358 |
Methods for Chk2 inhibitor patient selection
The present invention contemplates a method to identify subjects that either have a tumor, or are at risk for tumor development, that are responsive to various inhibitors of an activated-Chk2...
|
|
|
US20080103086 |
METHODS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE SECRETION OF HMGB1
The present invention relates to a pharmaceutical composition comprising an antagonist of the phosphorylation of HMGB1, and a method for treating a condition associated with activation of the...
|
|
|
US20080070826 |
Cholesterol-reducing diet
A method of treating cholesterol imbalance, high LDLs, and other metabolic syndrome problems and symptoms of osteoarthritis. The regimen preferred embodiment includes lipids as 60% or more of daily...
|
|
|
US20080051315 |
Grp Receptor-Related Methods for the Treating and Preventing Fear-Related Disorders
This invention provides a method for treating a subject afflicted with a fear-related disorder comprising administering to the subject a therapeutically effective amount of a gastrin-releasing...
|
|
|
US20080032966 |
Small Molecule Inhibitors of Mrp1 and Other Multidrug Transporters
A method of potentiating the activity of a therapeutic drug, like a chemotherapeutic drug or an antibiotic, in a cell or tissue, by inhibiting the efflux capability of a multidrug transporter are...
|
|
|
US20080032926 |
Knockout Non-Human Animal
The present invention relates to a knockout non-human animal whose genome comprises a disruption in at least one allele of the PHF3 gene, useful in developing drugs for diseases with the onset of...
|
|
|
US20080020964 |
Test System for the Discovery of Substances for the Promotion of Neuraxonal Growth
The invention relates to a method for identifying or testing active substances, which influence the growth and survival of nerve cells, wherein a cell is brought into contact with at least one...
|
|
|
US20080003297 |
Taste-masking oral dosage form and method of preparing the same
A taste-masking oral dosage form. The taste-masking oral dosage form comprises a pharmaceutically active ingredient, and a starch, wherein the pharmaceutically active ingredient is packaged by the...
|